CMED Initiates Dialogue on Review of Drug Pricing Rules
QR Group analyzes the impacts of the proposal on the pharmaceutical sector and how companies can prepare for the new regulatory scenario The Drug Market Regulation Chamber (CMED), linked to ANVISA, announced in July 2025 the start of a structured dialogue with the regulated sector to discuss the revision of drug pricing rules in Brazil. […]
